Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
PolandAll drugs from this manufacturer
-
The medicine is used in adult men for the treatment of prostate cancer that has spread to other parts of the body. It works by inhibiting the production of testosterone, which can slow the growth of the tumor.
Dosage form: tablets, film-coated
Active substance Dosage abiraterone acetate 500 mg ATC: L02BX03
-
It is used to treat the symptoms of mild enlargement of the prostate gland to facilitate the flow of urine from the bladder. It may also be used in acute urinary retention to help restore urine flow.
Dosage form: tablets, prolonged release
Active substance Dosage alfuzosin hydrochloride 10 mg ATC: G04CA01
-
The medicine is used in adults to prevent blood clots in the heart (in case of irregular heartbeat) and in the treatment and prevention of clots in the leg veins and pulmonary blood vessels. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.
Dosage form: tablets, film-coated
Active substance Dosage apixaban 5 mg ATC: B01AF02
-
Bucidar is a doctor-prescribed medication used in the treatment of depression.
Dosage form: tablets, modified release
Active substance Dosage bupropion hydrochloride 150 mg ATC: N06AX12
-
This medicine is prescribed by a doctor to treat depression.
Dosage form: tablets, modified release
Active substance Dosage bupropion hydrochloride 300 mg ATC: N06AX12
-
Byesilor is used as an adjunct in weight management for adults with obesity or overweight (with comorbid health conditions) and for adolescents with obesity. The medicine works by affecting the hunger center in the brain, which helps to reduce food intake. It is used in conjunction with a diet and increased physical activity.
Dosage form: solution for injection in a syringe
Active substance Dosage liraglutide 6 mg/ml ATC: A10BJ02
-
This medicine is used in adults to prevent blood clots from forming in hardened arteries. This helps to reduce the risk of stroke, heart attack, or death. It is prescribed, among others, to people after a heart attack, stroke, those with peripheral artery disease, unstable angina, or patients with atrial fibrillation.
Dosage form: tablets, film-coated
Active substance Dosage clopidogrel 75 mg ATC: B01AC04
-
This medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is also used to treat the lymphoblastic blast crisis of chronic myeloid leukemia in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 20 mg ATC: L01EA02
-
This medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is also used to treat the blast crisis phase of chronic myeloid leukemia in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 50 mg ATC: L01EA02
-
The medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is also used in the treatment of lymphoblastic blast crisis of chronic myeloid leukemia in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 70 mg ATC: L01EA02
-
It is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It helps to inhibit the growth of leukemia cells.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 80 mg ATC: L01EA02
-
The medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is also used in the treatment of blast crisis of chronic myeloid leukemia in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 100 mg ATC: L01EA02
-
This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age), as well as to treat acute lymphoblastic leukemia in adults, adolescents, and children (from 1 year of age), and in a specific form of myeloid leukemia in adults for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib 140 mg ATC: L01EA02
-
The medicine helps to lower blood sugar levels when they are too high. It also slows down the process of food passing through the stomach and may help prevent heart disease.
Dosage form: solution for injection in a syringe
Active substance Dosage liraglutide 6 mg/ml ATC: A10BJ02
-
This medicine is used to treat relapsing-remitting multiple sclerosis (MS) in people over 13 years of age. It is intended to prevent the immune system from damaging the brain and spinal cord and to slow the progression of the disease.
Dosage form: capsules, hard, intestinal
Active substance Dosage dimethyl fumarate 120 mg ATC: L04AX07
-
This medicine is used to treat relapsing-remitting multiple sclerosis (MS) in patients aged 13 years and older. It helps prevent the immune system from damaging the brain and spinal cord and may slow the progression of the disease.
Dosage form: capsules, hard, intestinal
Active substance Dosage dimethyl fumarate 240 mg ATC: L04AX07
-
The medicine is used to lower elevated cholesterol levels (total, 'bad' LDL cholesterol, and triglycerides) and increase 'good' HDL cholesterol levels. It is used as an adjunct to diet in individuals with hypercholesterolemia or in combination with statins, when diet and statins alone are insufficient to control cholesterol levels.
Dosage form: tablets
Active substance Dosage ezetimibe 10 mg ATC: C10AX09
-
Figozap is used to treat type 2 diabetes in adults and children over 10 years of age, heart failure in adults, and chronic kidney disease in adults.
Dosage form: tablets, film-coated
Active substance Dosage dapagliflozin 5 mg ATC: A10BK01
-
The medicine is used for the treatment of type 2 diabetes in adults and children over 10 years of age, in adults in the case of heart failure, and in adults with chronic kidney disease.
Dosage form: tablets, film-coated
Active substance Dosage dapagliflozin 10 mg ATC: A10BK01
-
The medicine is used in adults and children and adolescents (over 10 years of age and weighing more than 40 kg) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in individuals for whom treatment is not effective or in whom the disease is progressing rapidly and severely.
Dosage form: capsules, hard
Active substance Dosage fingolimod 0.5 mg ATC: L04AA27
-
This is an anticancer medication used in the treatment of patients with advanced or metastatic colorectal or rectal cancer. It may be administered in combination with other drugs or alone if the disease has recurred after previous therapy with fluorouracil.
Dosage form: solution for infusion
Active substance Dosage irinotecan hydrochloride trihydrate 1.5 mg/ml ATC: L01CE02
-
This medicine is used to treat cystic fibrosis in patients (aged 6 years and older and weighing at least 25 kg) who have been identified as having specific CFTR gene mutations (R117H or one of the gating mutations: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R).
Dosage form: tablets, film-coated
Active substance Dosage ivacaftor 150 mg ATC: R07AX02
-
It is used in adults and adolescents over 12 years of age to treat infections caused by bacteria. This includes, among others, upper and lower respiratory tract infections (e.g., pharyngitis, sinusitis, bronchitis, pneumonia), acute otitis media, skin and soft tissue infections, and infections caused by mycobacteria. It is also used to prevent certain infections in HIV patients and to treat duodenal ulcers caused by Helicobacter pylori bacteria.
Dosage form: tablets, film-coated
Active substance Dosage clarithromycin 500 mg ATC: J01FA09
-
The medicine is used for the long-term treatment of acromegaly (to relieve its symptoms, such as headaches, fatigue, or sweating) and in the treatment and inhibition of growth of certain advanced neuroendocrine tumors of the intestine and pancreas. It also helps to relieve hot flashes and diarrhea in patients with neuroendocrine tumors.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 71.5 mg ATC: H01CB03
-
This medicine is used for the long-term treatment of acromegaly (a condition involving excess growth hormone) and to inhibit the growth of certain advanced neuroendocrine tumors in the intestines and pancreas. It also helps relieve symptoms such as hot flashes, diarrhea, fatigue, headaches, or joint pain.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 107.2 mg ATC: H01CB03
-
The medicine is used for the long-term treatment of acromegaly (to relieve its symptoms, such as headaches, fatigue, or sweating) and for the treatment and inhibition of growth of certain advanced neuroendocrine tumors of the intestine and pancreas. It also helps to relieve hot flashes and diarrhea in patients with neuroendocrine tumors.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 143.0 mg ATC: H01CB03
-
This medicine is used for the long-term treatment of acromegaly (excess growth hormone) and to relieve its symptoms, such as headaches, fatigue, or sweating. It is also used in the treatment and inhibition of growth of certain advanced neuroendocrine tumors in the intestine and pancreas, and to relieve symptoms (e.g., hot flashes and diarrhea) associated with these tumors.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 71.5 mg ATC: H01CB03
-
The medicine is used for the long-term treatment of acromegaly (excess growth hormone) and to relieve its symptoms, such as headaches, fatigue, or sweating. It is also used for the treatment and inhibition of growth of certain advanced neuroendocrine tumors in the intestines and pancreas, and to relieve symptoms (e.g., hot flashes and diarrhea) associated with these tumors.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 107.2 mg ATC: H01CB03
-
The medicine is used for the long-term treatment of acromegaly (a condition of excess growth hormone) and to relieve its symptoms, such as headaches, fatigue, or sweating. It is also used for the treatment and inhibition of growth of advanced neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NET) and to relieve symptoms such as hot flashes and diarrhea in patients with these tumors.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 143 mg ATC: H01CB03
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
-
The medicine is used to induce a state of deep sedation and sleep in adult patients in intensive care units. It also helps to relieve anxiety and reduce muscle tension.
Dosage form: solution for injection or infusion in ampoule-syringe
Active substance Dosage midazolam 1 mg/ml ATC: N05CD08
-
The medicine is used to induce a state of deep sedation and sleep in adult patients in intensive care units. It also helps to relieve symptoms of anxiety and reduce muscle tension.
Dosage form: solution for injection or infusion in ampoule-syringe
Active substance Dosage midazolam 2 mg/ml ATC: N05CD08
-
Nableran is an antibiotic used to treat severe bacterial infections in adults and children over 3 months of age. It may be prescribed for lung infections (e.g., pneumonia, cystic fibrosis), urinary tract infections, abdominal infections, skin and soft tissue infections, perinatal infections, meningitis, and bloodstream infections.
Dosage form: powder for preparation of solution for injection or infusion
Active substance Dosage meropenem 570 mg ATC: J01DH02
-
Nableran is an antibiotic used to treat severe bacterial infections in adults and children over 3 months of age. It may be prescribed for lung infections (pneumonia), urinary tract infections, abdominal infections, skin and soft tissue infections, perinatal infections, meningitis, and bloodstream infections.
Dosage form: powder for preparation of solution for injection or infusion
Active substance Dosage meropenem 1400 mg ATC: J01DH02
-
The medicinal product is intended for adult patients for the treatment of acute hypotension occurring in shock.
Dosage form: solution for infusion in pre-filled syringe
Active substance Dosage norepinephrine 0,5 mg/ml ATC: C01CA03
-
The medicine is used to treat type 2 diabetes in adults when diet, physical exercise, and weight loss are not sufficient to maintain proper blood sugar levels.
Dosage form: tablets, modified release
Active substance Dosage gliclazide 60 mg ATC: A10BB09
-
The medicine is used to treat high blood pressure, reduce the risk of heart attack or stroke, protect the kidneys (regardless of the presence of diabetes), as well as in the treatment of heart failure and in patients following a heart attack.
Dosage form: tablets
Active substance Dosage ramipril 2.5 mg ATC: C09AA05
-
The medicine is used to treat high blood pressure, heart failure (including after a heart attack), and to reduce the risk of a heart attack or stroke. It also helps protect the kidneys and delay the worsening of their function.
Dosage form: tablets
Active substance Dosage ramipril 5 mg ATC: C09AA05
-
It is used to treat high blood pressure, reduce the risk of heart attack or stroke, and to delay the worsening of kidney disease. It is also used in the treatment of heart failure and in patients following a heart attack.
Dosage form: tablets
Active substance Dosage ramipril 10 mg ATC: C09AA05
-
It is used to relieve symptoms associated with an enlarged prostate (benign prostatic hyperplasia). It helps with difficulties in urination (e.g., weak stream), urgency, and frequent urination during the day and night.
Dosage form: capsules, extended release
Active substance Dosage tamsulosin hydrochloride 0.4 mg ATC: G04CA02
-
Ridlip is used to treat high cholesterol levels in adults, adolescents, and children aged 6 years and older. It helps to lower 'bad' cholesterol (LDL-C) and increase 'good' cholesterol (HDL-C), which reduces the risk of heart attack, stroke, or other atherosclerosis-related diseases.
Dosage form: tablets, film-coated
Active substance Dosage rosuvastatin 0,25 g/100 g ATC: C10AA07
-
This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular causes following acute coronary syndrome. It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 2.5 mg ATC: B01AF01
-
The medicine is used in adults to prevent blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg ATC: B01AF01
-
The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat clots after initial injectable treatment.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg ATC: B01AF01